Regulators on both sides of the Atlantic are pushing for the withdrawal of the rare disease treatment that accounted for just 1% of Amgen’s 2025 revenue. Nevertheless, Amgen continues to defend the ...

Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, ...

The European Medicines Agency (EMA) has recommended that marketing authorisation for Tavneos (avacopan) be revoked due to a ...

The European Medicines Agency has called for Tavneos, a medication owned by Amgen and licensed in Europe by CSL's Vifor, to have its marketing authorization revoked.

Amgen (AMGN) is facing a possible withdrawal of its rare-disorder therapy, Tavneos, in the EU after an expert panel of the European Medicines Agency recommended its marketing authorization be revoked ...

June 26 (Reuters) - Europe's drug regulator on Friday recommended revoking the marketing authorization for Amgen's rare autoimmune disease medicine, citing concerns over the integrity of its trial ...

The FDA wants to withdraw approval of Amgen’s drug after years on the market. The company is defending it.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Fake USB sticks used by the Japanese army spread a China-linked ...

Of the 400 million patients worldwide diagnosed with rare diseases, about 250 million of them live in North and Southeast Asia 1. That includes patients in major markets such as China and Japan, as ...

OKLAHOMA CITY (KFOR) – The Centers for Disease Control and Prevention states heart disease is the leading cause of death in the U.S. A new study puts Oklahoma at the very top in the country for heart ...